Skip to main content
. 2016 Dec 6;116(1):10–20. doi: 10.1038/bjc.2016.405

Figure 3.

Figure 3

Design of important clinical trials comparing aromatase inhibitors alone vs aromatase inhibitors given in combinations with novel targeted therapies. MBC=metastatic breast cancer; NST-AI=nonsteroidal aromatase inhibitor; PMW=postmenopausal women.